Characteristics | Comparison of HT | Comparison of PH | ||||
---|---|---|---|---|---|---|
No HT (n=115) | HT (n=91) | p Value | No PH (n=167) | PH (n=39) | p Value | |
Age, years | 64 (18) | 70 (17) | 0.023 | 66 (18) | 70 (18) | 0.173 |
Female sex, % | 73 (63.5) | 46 (50.5) | 0.067 | 99 (59.3) | 20 (51.3) | 0.374 |
NIHSS, score | 17 (7) | 19 (6) | 0.093 | 17 (7) | 20 (6) | 0.007 |
Glucose, mg/dL | 116 (70–417) | 128 (80–414) | 0.036 | 120 (70–417) | 134 (89–238) | 0.075 |
Any CMBs, % | 23 (20.0) | 14 (15.4) | 0.466 | 31 (18.6) | 6 (15.4) | 0.818 |
CMBs distribution | ||||||
Strictly lobar, % | 7 (6.1) | 5 (5.5) | 1.000 | 10 (6.0) | 2 (5.1) | 1.000 |
Strictly deep, % | 8 (7.0) | 4 (4.4) | 0.555 | 10 (6.0) | 2 (5.1) | 1.000 |
Strictly infratentorial, % | 1 (0.9) | 1 (1.1) | 1.000 | 2 (1.2) | 0 (0.0) | 1.000 |
Mixed, % | 7 (6.1) | 4 (4.4) | 0.758 | 9 (5.4) | 2 (5.1) | 1.000 |
CMBs number, % | ||||||
1 | 13 (11.3) | 10 (11.0) | 1.000 | 19 (11.4) | 4 (10.3) | 1.000 |
2–4 | 10 (8.7) | 3 (3.3) | 0.152 | 11 (6.6) | 2 (5.1) | 1.000 |
≥5 | 0 (0.0) | 1/91 (1.1) | 0.442 | 1 (0.6) | 0/39 (0.0) | 1.000 |
CMBs coexisting with WMH, % | ||||||
Overall WMH | 37 (32.5) | 45 (50.0) | 0.014 | 60 (36.4) | 22 (56.4) | 0.029 |
CMBs and overall WMH | 14 (12.3) | 8 (8.9) | 0.501 | 18 (10.9) | 4 (10.3) | 1.000 |
CMBs and deep WMH | 9 (7.9) | 5 (5.6) | 0.586 | 10 (6.1) | 4 (10.3) | 0.313 |
CMBs ≥2 and overall WMH | 4 (3.5) | 1 (1.1) | 0.386 | 4 (2.4) | 1 (2.6) | 1.000 |
Data are represented as mean (SD), median (IQR) or number (percentage). HTs were categorized as hemorrhagic infarction or parenchymal hematoma according to the European Cooperative Acute Stroke Study definition.
CMBs, cerebral microbleeds; HT, hemorrhagic transformation; NIHSS, National Institutes of Health Stroke Scale; PH, parenchymal hematoma; WMH, white matter hyperintensity.